# OnCo record michael-migden (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/michael-migden/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "michael-migden" ;
  schema:name "Michael R. Migden"@en ;
  schema:description "Houston dermatologist who led the trials that established cemiplimab, the first drug approved for advanced cutaneous squamous-cell carcinoma, and sonidegib for basal cell carcinoma."@en ;
  schema:url <https://onco.cc/people/michael-migden/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "skin", "immunotherapy", "trialist" ;
  schema:jobTitle "Dermatologist and Mohs surgeon, MD Anderson Cancer Center" ;
  onco:cancers <https://onco.cc/cancers/advanced-cutaneous-scc/>, <https://onco.cc/cancers/locally-advanced-bcc/>, <https://onco.cc/cancers/skin-cancer/> ;
  onco:institutions <https://onco.cc/institutions/md-anderson/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-empower-cscc-1-cemiplimab-migden-nejm-2018/>, <https://onco.cc/key-papers/paper-bolt-sonidegib-migden-lancet-oncol-2015/> ;
  schema:affiliation <https://onco.cc/institutions/md-anderson/> .